← All organizations

Sharpe-Strumia Research Foundation

Academic/HospitalWebsite ↗

Also known as: Sharpe-Strumia Research Foundation

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Last known activity

May 27, 2020

Timeline

2000s

Jan 1, 2003
Sharpe-Strumia Research Foundation— Founded

Drugs by trial phase (6 distinct, 6 trials)

Phase 4 (3 own, 0 via acquisition)

Phase 1 (2 own, 0 via acquisition)

Other trials (1 own, 0 via acquisition)

rimabotulinumtoxinB

Indications

Studied for

Recent trials (6)

NCT04652648CollaboratorPhase 4May 27, 2020
NCT04290208CollaboratorPhase 4Aug 22, 2019
NCT03864588CollaboratorPhase 4Oct 1, 2018
NCT01829087CollaboratorN/AAug 1, 2012
NCT01984580CollaboratorPhase 1Apr 1, 2011
NCT00216788CollaboratorPhase 1Jan 1, 2006

Details

Founded: Bryn Mawr, PA, US Jan 1, 2003
Last known activity: May 27, 2020